$TRNS
TRANSCAT INC

2023 Q4 Form 10-Q Financial Statement

#000143774923029757 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $65.17M $62.80M
YoY Change 13.53% 11.28%
Cost Of Revenue $44.23M $42.68M
YoY Change 7.87% 7.58%
Gross Profit $20.94M $20.13M
YoY Change 27.66% 20.03%
Gross Profit Margin 32.13% 32.04%
Selling, General & Admin $16.64M $18.48M
YoY Change 25.72% 40.64%
% of Gross Profit 79.49% 91.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.761M $3.290M
YoY Change 33.18% 18.43%
% of Gross Profit 17.96% 16.35%
Operating Expenses $16.64M $18.48M
YoY Change 25.72% 40.64%
Operating Profit $4.294M $1.643M
YoY Change 35.76% -54.69%
Interest Expense $81.00K -$890.0K
YoY Change -111.16% 61.82%
% of Operating Profit 1.89% -54.17%
Other Income/Expense, Net -$23.00K -$841.0K
YoY Change -97.79% 56.61%
Pretax Income $4.271M $802.0K
YoY Change 101.08% -74.04%
Income Tax $923.0K $342.0K
% Of Pretax Income 21.61% 42.64%
Net Earnings $3.348M $460.0K
YoY Change 109.12% -80.48%
Net Earnings / Revenue 5.14% 0.73%
Basic Earnings Per Share $0.39 $0.06
Diluted Earnings Per Share $0.38 $0.06
COMMON SHARES
Basic Shares Outstanding 8.826M 7.688M
Diluted Shares Outstanding 8.752M 7.948M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.21M $1.200M
YoY Change 2109.98% 32.01%
Cash & Equivalents $35.21M $1.246M
Short-Term Investments
Other Short-Term Assets $3.295M $3.500M
YoY Change -20.43% -20.8%
Inventory $16.18M $15.69M
Prepaid Expenses
Receivables $43.31M $44.38M
Other Receivables $819.0K $335.0K
Total Short-Term Assets $98.80M $65.17M
YoY Change 62.78% 4.08%
LONG-TERM ASSETS
Property, Plant & Equipment $37.22M $35.65M
YoY Change 31.37% 28.37%
Goodwill $105.7M $106.4M
YoY Change 53.58% 60.87%
Intangibles $21.46M $23.16M
YoY Change 44.57% 55.62%
Long-Term Investments
YoY Change
Other Assets $1.055M $1.083M
YoY Change 17.88% 34.53%
Total Long-Term Assets $182.3M $183.0M
YoY Change 42.65% 47.49%
TOTAL ASSETS
Total Short-Term Assets $98.80M $65.17M
Total Long-Term Assets $182.3M $183.0M
Total Assets $281.1M $248.2M
YoY Change 49.14% 32.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.36M $12.52M
YoY Change -17.98% -7.91%
Accrued Expenses $13.81M $11.50M
YoY Change 53.21% 26.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.316M $2.293M
YoY Change 4.0% 3.99%
Total Short-Term Liabilities $29.35M $28.11M
YoY Change 17.02% 12.94%
LONG-TERM LIABILITIES
Long-Term Debt $2.411M $51.00M
YoY Change -94.86% 4.92%
Other Long-Term Liabilities $5.527M $5.477M
YoY Change 270.94% 267.09%
Total Long-Term Liabilities $7.938M $56.48M
YoY Change -83.61% 12.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.35M $28.11M
Total Long-Term Liabilities $7.938M $56.48M
Total Liabilities $62.60M $110.0M
YoY Change -32.82% 16.49%
SHAREHOLDERS EQUITY
Retained Earnings $74.37M $71.02M
YoY Change 13.53% 11.13%
Common Stock $144.8M $68.30M
YoY Change 368.55% 128.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $218.5M $138.3M
YoY Change
Total Liabilities & Shareholders Equity $281.1M $248.2M
YoY Change 49.14% 32.93%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $3.348M $460.0K
YoY Change 109.12% -80.48%
Depreciation, Depletion And Amortization $3.761M $3.290M
YoY Change 33.18% 18.43%
Cash From Operating Activities $10.92M $8.430M
YoY Change 24.93% 164.1%
INVESTING ACTIVITIES
Capital Expenditures $3.659M $2.670M
YoY Change 53.93% -212.52%
Acquisitions
YoY Change
Other Investing Activities -$52.00K -$10.01M
YoY Change -98.78%
Cash From Investing Activities -$3.701M -$12.69M
YoY Change -44.29% 434.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.77M 3.170M
YoY Change -1877.29% -485.64%
NET CHANGE
Cash From Operating Activities 10.92M 8.430M
Cash From Investing Activities -3.701M -12.69M
Cash From Financing Activities 26.77M 3.170M
Net Change In Cash 33.98M -1.090M
YoY Change 5650.25% 36233.33%
FREE CASH FLOW
Cash From Operating Activities $10.92M $8.430M
Capital Expenditures $3.659M $2.670M
Free Cash Flow $7.260M $5.760M
YoY Change 14.1% 3.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-25
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
614000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
457000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7978401
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7978401
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7562604
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7562604
CY2023Q1 us-gaap Investments
Investments
200000 usd
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-23
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-03905
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-0874418
dei Entity Address Address Line1
EntityAddressAddressLine1
35 Vantage Point Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Rochester
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14624
dei City Area Code
CityAreaCode
585
dei Local Phone Number
LocalPhoneNumber
352-7777
dei Security12b Title
Security12bTitle
Common Stock, $0.50 par value
dei Trading Symbol
TradingSymbol
TRNS
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8826324
CY2023Q3 us-gaap Revenues
Revenues
62804000 usd
CY2022Q3 us-gaap Revenues
Revenues
56439000 usd
us-gaap Revenues
Revenues
123402000 usd
us-gaap Revenues
Revenues
111100000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42679000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39672000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
84567000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
78295000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
20125000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
16767000 usd
us-gaap Gross Profit
GrossProfit
38835000 usd
us-gaap Gross Profit
GrossProfit
32805000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6856000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5900000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13325000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11720000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11626000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7241000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19227000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13855000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18482000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
13141000 usd
us-gaap Operating Expenses
OperatingExpenses
32552000 usd
us-gaap Operating Expenses
OperatingExpenses
25575000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1643000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3626000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6283000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
7230000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-841000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-537000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1719000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-693000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
802000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3089000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4564000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6537000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
732000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1155000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1108000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2357000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
us-gaap Net Income Loss
NetIncomeLoss
5429000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.72
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7819000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7550000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7732000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7542000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7948000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7646000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7840000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7635000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2357000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
us-gaap Net Income Loss
NetIncomeLoss
5429000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-352000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-831000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
124000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1271000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-346000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-838000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
136000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1291000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
114000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1519000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3545000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4138000 usd
CY2023Q3 us-gaap Cash
Cash
1246000 usd
CY2023Q1 us-gaap Cash
Cash
1531000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44382000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44698000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
335000 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
506000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
15685000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
16929000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3525000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3935000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
65173000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
67599000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35648000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29064000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
106366000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
69360000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23156000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13799000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16784000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14876000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1083000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1051000 usd
CY2023Q3 us-gaap Assets
Assets
248210000 usd
CY2023Q1 us-gaap Assets
Assets
195749000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
12523000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15869000 usd
CY2023Q3 trns Accrued Compensation And Other Liabilities Current
AccruedCompensationAndOtherLiabilitiesCurrent
13295000 usd
CY2023Q1 trns Accrued Compensation And Other Liabilities Current
AccruedCompensationAndOtherLiabilitiesCurrent
10201000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2293000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2248000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
28111000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
28318000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
51000000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
46869000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10836000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6538000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14534000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12960000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5477000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1434000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
109958000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
96119000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
3989000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3781000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
64310000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27886000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1064000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1200000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
71017000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
69163000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
138252000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99630000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
248210000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
195749000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
us-gaap Net Income Loss
NetIncomeLoss
5429000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-34000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
23000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-54000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6078000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5419000 usd
trns Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown
AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown
347000 usd
trns Accounts Receivable Credit Loss Expense Reversal And Inventory Writedown
AccountsReceivableCreditLossExpenseReversalAndInventoryWritedown
94000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2171000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1942000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-2384000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1238000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3376000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3724000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-465000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-881000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3969000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-586000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1677000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2962000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15972000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5235000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5444000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4772000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12882000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4040000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18326000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8802000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
5288000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
3387000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1112000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1026000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
384000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
364000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2247000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
437000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2313000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2288000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-244000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
792000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-285000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-487000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1531000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1396000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1246000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
909000 usd
us-gaap Interest Paid Net
InterestPaidNet
1680000 usd
us-gaap Interest Paid Net
InterestPaidNet
829000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1099000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
484000 usd
us-gaap Stock Issued1
StockIssued1
34769000 usd
us-gaap Stock Issued1
StockIssued1
145000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
86176000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
366000 usd
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
437000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
828000 usd
CY2022Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-453000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
3072000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
89552000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
143000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1114000 usd
CY2022Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-838000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2357000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
92328000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
99630000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7030000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
301000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
930000 usd
CY2023Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
482000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2949000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
110720000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28123000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1946000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1241000 usd
CY2023Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-346000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
138252000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates: </b>The preparation of Transcat’s Consolidated Financial Statements in accordance with GAAP requires that the Company make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions are used for, but <em style="font: inherit;">not</em> limited to, allowance for doubtful accounts and returns, inventory reserves, estimated levels of achievement for performance-based restricted stock units, fair value of stock options, depreciable lives of fixed assets, estimated lives of major catalogs and intangible assets, fair value of the goodwill reporting units, and the valuation of assets acquired, liabilities assumed and consideration transferred in business acquisitions. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the Consolidated Financial Statements <em style="font: inherit;"> may </em>change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. Actual results could differ from those estimates. Such changes and refinements in estimation methodologies are reflected in reported results of operations in the period in which the changes are made and, if material, their effects are disclosed in the Notes to the Consolidated Financial Statements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
300000 usd
CY2023Q3 us-gaap Investments
Investments
200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
100000 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
100000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
100000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
trns Dilutive Securities Effect Per Share On Earnings
DilutiveSecuritiesEffectPerShareOnEarnings
0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7819000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7550000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7732000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7542000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
129000
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
96000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
108000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
93000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7948000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7646000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7840000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7635000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
166000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
37000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
166000
CY2023Q1 us-gaap Goodwill
Goodwill
69360000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13799000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
36890000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
11883000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
-0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2528000 usd
CY2023Q3 us-gaap Revenues
Revenues
62804000 usd
CY2022Q3 us-gaap Revenues
Revenues
56439000 usd
us-gaap Revenues
Revenues
123402000 usd
us-gaap Revenues
Revenues
111100000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
116000 usd
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
2000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
106366000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23156000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3440000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3243000 usd
CY2023Q3 trns Accrued Incentive Current
AccruedIncentiveCurrent
1873000 usd
CY2023Q1 trns Accrued Incentive Current
AccruedIncentiveCurrent
2507000 usd
CY2023Q3 trns Current Portion Of Lease Liabilities
CurrentPortionOfLeaseLiabilities
2749000 usd
CY2023Q1 trns Current Portion Of Lease Liabilities
CurrentPortionOfLeaseLiabilities
2333000 usd
CY2023Q3 trns Accrued Acquisition Holdbacks Current
AccruedAcquisitionHoldbacksCurrent
2525000 usd
CY2023Q1 trns Accrued Acquisition Holdbacks Current
AccruedAcquisitionHoldbacksCurrent
252000 usd
CY2023Q3 trns Accrued Contingent Consideration
AccruedContingentConsideration
942000 usd
CY2023Q1 trns Accrued Contingent Consideration
AccruedContingentConsideration
0 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1766000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1866000 usd
CY2023Q3 trns Accrued Compensation And Other Current Liabilities
AccruedCompensationAndOtherCurrentLiabilities
13295000 usd
CY2023Q1 trns Accrued Compensation And Other Current Liabilities
AccruedCompensationAndOtherCurrentLiabilities
10201000 usd
CY2023Q3 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1254000 usd
CY2023Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
1266000 usd
CY2023Q3 trns Accrued Acquisition Holdbacks Noncurrent
AccruedAcquisitionHoldbacksNoncurrent
1647000 usd
CY2023Q1 trns Accrued Acquisition Holdbacks Noncurrent
AccruedAcquisitionHoldbacksNoncurrent
0 usd
CY2023Q3 trns Accrued Contingent Consideration Noncurrent
AccruedContingentConsiderationNoncurrent
2358000 usd
CY2023Q1 trns Accrued Contingent Consideration Noncurrent
AccruedContingentConsiderationNoncurrent
0 usd
CY2023Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
218000 usd
CY2023Q1 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
168000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5477000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1434000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
20125000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
16767000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
600000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
217000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
56.25
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
27000
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
93.28
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4000
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
24.30
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
63.17
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
238000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
60.89
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8130000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
60000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
55.34
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2348000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
us-gaap Gross Profit
GrossProfit
38835000 usd
us-gaap Gross Profit
GrossProfit
32805000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
18482000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
13141000 usd
us-gaap Operating Expenses
OperatingExpenses
32552000 usd
us-gaap Operating Expenses
OperatingExpenses
25575000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1643000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3626000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6283000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
7230000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-841000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-537000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1719000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-693000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
732000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1155000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1108000 usd
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
1183000 usd
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
1269000 usd
us-gaap Other General Expense
OtherGeneralExpense
2874000 usd
us-gaap Other General Expense
OtherGeneralExpense
1801000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
460000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
2357000 usd
us-gaap Net Income Loss
NetIncomeLoss
3409000 usd
us-gaap Net Income Loss
NetIncomeLoss
5429000 usd
CY2023Q3 us-gaap Revenues
Revenues
62804000 usd
CY2022Q3 us-gaap Revenues
Revenues
56439000 usd
us-gaap Revenues
Revenues
123402000 usd
us-gaap Revenues
Revenues
111100000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
66077000 usd
CY2022Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
62280000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
131550000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
123410000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
422000 usd
CY2022Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1670000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3085000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3975000 usd
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.05
CY2022Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.22
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.40
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.53
CY2023Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.05
CY2022Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.22
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.39
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.52
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
900000 usd
CY2023Q3 trns Unpaid Amounts For Other Holdbacks
UnpaidAmountsForOtherHoldbacks
2500000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2400000 usd
trns Payments For Other Holdbacks
PaymentsForOtherHoldbacks
1600000 usd
trns Payments For Other Holdbacks
PaymentsForOtherHoldbacks
0 usd

Files In Submission

Name View Source Status
0001437749-23-029757-index-headers.html Edgar Link pending
0001437749-23-029757-index.html Edgar Link pending
0001437749-23-029757.txt Edgar Link pending
0001437749-23-029757-xbrl.zip Edgar Link pending
ex_568662.htm Edgar Link pending
ex_568663.htm Edgar Link pending
ex_568664.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trns-20230923.xsd Edgar Link pending
trns20230911_10q.htm Edgar Link pending
trns-20230923_cal.xml Edgar Link unprocessable
trns-20230923_lab.xml Edgar Link unprocessable
trns-20230923_pre.xml Edgar Link unprocessable
trns-20230923_def.xml Edgar Link unprocessable
trns20230911_10q_htm.xml Edgar Link completed